These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 10145580)

  • 1. Evaluation of a double-enclosure double-vacuum unit scavenging system for ribavirin administration.
    Kacmarek RM; Kratohvil J
    Respir Care; 1992 Jan; 37(1):37-45. PubMed ID: 10145580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ribavirin aerosol: methods for reducing employee exposure.
    Arnold SD; Alonso R
    AAOHN J; 1993 Aug; 41(8):382-92. PubMed ID: 8397555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protecting hospital employees and visitors from aerosolized ribavirin.
    Munzenberger PJ; Walker PC
    Am J Hosp Pharm; 1994 Mar; 51(6):823-6. PubMed ID: 8010325
    [No Abstract]   [Full Text] [Related]  

  • 4. Administration of ribavirin to neonatal and pediatric patients during mechanical ventilation.
    Demers RR; Parker J; Frankel LR; Smith DW
    Respir Care; 1986 Dec; 31(12):1188-96. PubMed ID: 10315718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced environmental exposure to aerosolized ribavirin using a simple containment system.
    Torres A; Krilov LR; Jacobson JM; Kelly KJ; Havens PL
    Pediatr Infect Dis J; 1991 Mar; 10(3):217-21. PubMed ID: 2041670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ribavirin administration via scavenger vacuum systems in the treatment of respiratory syncytial virus (RSV).
    Adams DA
    J Pediatr Nurs; 1994 Feb; 9(1):51-4. PubMed ID: 8201541
    [No Abstract]   [Full Text] [Related]  

  • 7. Occupational exposure to nitrous oxide - the role of scavenging and ventilation systems in reducing the exposure level in operating rooms.
    Krajewski W; Kucharska M; Wesolowski W; Stetkiewicz J; Wronska-Nofer T
    Int J Hyg Environ Health; 2007 Mar; 210(2):133-8. PubMed ID: 17045524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of an in-house-built ribavirin aerosol evacuation system to control incidental employee exposure to ribavirin aerosol.
    Mueller BA; Waldon VK
    J Clin Eng; 1996; 21(1):46-50. PubMed ID: 10154627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Technical communication: An initial evaluation of a novel anesthetic scavenging interface.
    Barwise JA; Lancaster LJ; Michaels D; Pope JE; Berry JM
    Anesth Analg; 2011 Nov; 113(5):1064-7. PubMed ID: 21865500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of exposure of health care personnel to ribavirin.
    Gladu JM; Ecobichon DJ
    J Toxicol Environ Health; 1989; 28(1):1-12. PubMed ID: 2778845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Canada and the U.S. differ on ribavirin risk.
    Healthc Hazard Mater Manage; 1991 Jun; 4(9):8. PubMed ID: 10112449
    [No Abstract]   [Full Text] [Related]  

  • 12. Environmental exposure to ribavirin aerosol.
    Bradley J
    Pediatr Infect Dis J; 1990 Sep; 9(9 Suppl):S95-8. PubMed ID: 2235216
    [No Abstract]   [Full Text] [Related]  

  • 13. Update: ribavirin exposure.
    Healthc Hazard Mater Manage; 1991 Jan; 4(4):1-4. PubMed ID: 10111085
    [No Abstract]   [Full Text] [Related]  

  • 14. Ribavirin aerosol therapy: safety for staff.
    Bortolussi RA; Gold R
    CMAJ; 1988 Feb; 138(3):204. PubMed ID: 3337982
    [No Abstract]   [Full Text] [Related]  

  • 15. Personal protective equipment. I: chemical protective clothing and respirators.
    Hosp Hazard Mater Manage; 1989 Oct; 3(1):1-10. PubMed ID: 10304349
    [No Abstract]   [Full Text] [Related]  

  • 16. Assessing exposures of health-care personnel to aerosols of ribavirin--California.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1988 Sep; 37(36):560-3. PubMed ID: 3137440
    [No Abstract]   [Full Text] [Related]  

  • 17. An industrial hygiene approach to controlling nonpatient exposure to ribavirin aerosol.
    Kayman L
    Pediatr Infect Dis J; 1990 Sep; 9(9 Suppl):S100-1. PubMed ID: 2235201
    [No Abstract]   [Full Text] [Related]  

  • 18. Respiratory syncytial virus upper respiratory tract illnesses in adult blood and marrow transplant recipients: combination therapy with aerosolized ribavirin and intravenous immunoglobulin.
    Ghosh S; Champlin RE; Englund J; Giralt SA; Rolston K; Raad I; Jacobson K; Neumann J; Ippoliti C; Mallik S; Whimbey E
    Bone Marrow Transplant; 2000 Apr; 25(7):751-5. PubMed ID: 10745261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exposure of health care workers to ribavirin during therapy for respiratory syncytial virus infections.
    Bradley JS; Connor JD; Compogiannis LS; Eiger LL
    Antimicrob Agents Chemother; 1990 Apr; 34(4):668-70. PubMed ID: 2344173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Field evaluation of an engineering control for respirable crystalline silica exposures during mortar removal.
    Collingwood S; Heitbrink WA
    J Occup Environ Hyg; 2007 Nov; 4(11):875-87. PubMed ID: 17917951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.